Back

Clinical outcomes in >10,000 Asian vs >61,000 Non-Asian race patients with AF randomized to Warfarin vs DOACs: a patient-level meta-analyses from COMBINE AF

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Risk assessment and prevention of brain infarction in atrial fibrillation Oral Anticoagulation ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Tze-Fan Chao

Taipei Veterans General Hospital, Taipei (Taiwan)

8 More presentations in this session

Presentation thumbnail
Incidence of silent brain injury in pacemaker implanted patients with atrial high-speed episodes (AHRE)
Doctor M. Uyanik (Samsun, TR)
Abstract Slides Video
Presentation thumbnail
Altered fibrin clot properties and elevated von Willebrand Factors level are associated with progression to permanent atrial fibrillation during follow-up: a cohort study
Doctor K. Nowak (Krakow, PL)
Abstract Slides Video
Presentation thumbnail
The triglyceride-glucose index is a marker of thromboembolic events in atrial fibrillation patient under oral anticoagulation therapy
Doctor J. Rivera-Caravaca (Murcia, ES)
Abstract Slides Video
Presentation thumbnail
Resolution of silent left atrial thrombi and clinical outcomes in patients with atrial fibrillation: insight from the LAT trial
Doctor N. Tanaka (Osaka, JP)
Abstract Slides Video
Presentation thumbnail
Evaluation of the biomarker-based ABC-AF-bleeding risk score and clinically based bleeding scores in 31,605 patients with atrial fibrillation treated with oral anticoagulation
Associate Professor Z. Hijazi (Uppsala, SE)
Abstract Slides Video

Access the full session

Session thumbnail
Risk assessment and prevention of brain infarction in atrial fibrillation

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Comparisons of effectiveness and safety between different dosage strategy in patients with atrial fibrillation treated with rivaroxaban: a systemic review and meta-analysis
thumbnail
Congress Presentation
Temporal trends of prescription rates, dosing of non-vitamin K antagonist oral anticoagulants and clinical outcomes in patients with atrial fibrillation
thumbnail
Congress Presentation
Switching from warfarin to a DOAC in frail elderly asian patients with atrial fibrillation: a nationwide population-based study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources